| Literature DB >> 26746583 |
Chetak Kandaswamy1, Luís M Silva2, Luís A Alexandre3, Jorge M Santos4.
Abstract
High-content analysis has revolutionized cancer drug discovery by identifying substances that alter the phenotype of a cell, which prevents tumor growth and metastasis. The high-resolution biofluorescence images from assays allow precise quantitative measures enabling the distinction of small molecules of a host cell from a tumor. In this work, we are particularly interested in the application of deep neural networks (DNNs), a cutting-edge machine learning method, to the classification of compounds in chemical mechanisms of action (MOAs). Compound classification has been performed using image-based profiling methods sometimes combined with feature reduction methods such as principal component analysis or factor analysis. In this article, we map the input features of each cell to a particular MOA class without using any treatment-level profiles or feature reduction methods. To the best of our knowledge, this is the first application of DNN in this domain, leveraging single-cell information. Furthermore, we use deep transfer learning (DTL) to alleviate the intensive and computational demanding effort of searching the huge parameter's space of a DNN. Results show that using this approach, we obtain a 30% speedup and a 2% accuracy improvement.Entities:
Keywords: cancer drug discovery; deep transfer learning; high-content screening; image analysis
Mesh:
Substances:
Year: 2016 PMID: 26746583 DOI: 10.1177/1087057115623451
Source DB: PubMed Journal: J Biomol Screen ISSN: 1087-0571